Shwachman Diamond Syndrome Registry and Study (SDS Registry)

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse regarding the clinical features, natural history, clinical outcomes with current management, and treatment. For this reason, the SDS Registry was formed to collect clinical data from medical records and to bank biological samples with the goal of understanding SDS/SDS-Like diseases to develop better treatments and improve the health of patients with these conditions.

Eligibility
Participation Requirements
Sex: All
View:

• Biallelic mutations in SBDS, or pathogenic mutations in DNAJC21, EFL1, or SRP54 OR

• Shwachman-Diamond Syndrome defined clinically OR

• Clinically suspected Shwachman-Diamond Syndrome OR

• Phenotypic features suggestive of SDS OR

• Parents, siblings, and other blood relatives of any age, living and deceased, of patients with SDS or SDS-Like conditions are eligible for this study

Locations
United States
Colorado
Children's Hospital Colorado
RECRUITING
Aurora
Massachusetts
Boston Children's Hospital
RECRUITING
Boston
Dana-Farber Cancer Institute
RECRUITING
Boston
Ohio
Cincinnati Children's Hospital Medical Center
RECRUITING
Cincinnati
Contact Information
Primary
Akiko Shimamura, MD, PhD
akiko.shimamura@childrens.harvard.edu
Backup
Karyn Brundige
sdsregistry-dl@childrens.harvard.edu
Time Frame
Start Date: 2016-01-19
Estimated Completion Date: 2090-01-01
Participants
Target number of participants: 5000
Treatments
Patients with SDS/SDS-Like conditions and their families
Related Therapeutic Areas
Sponsors
Collaborators: Children's Hospital Medical Center, Cincinnati
Leads: Boston Children's Hospital

This content was sourced from clinicaltrials.gov